SETH SANDESH (CEO) reported 1 transaction at ACTINIUM PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/20/2025ACC: 0001213900-25-079019
DirectorOfficer· CEO
Since Jul 2018
-120.90K
Net shares
Net seller
$206.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
120.90K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−120.90K
Price / share
$1.71
Trade value
$206.74K
% of position
39.6%
8/18/2025
305.38K→184.48K
Total
Net shares
−120.90K
Net value
-$206.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2025 | F · Tax Withholding | −120.90K | $1.71 | $206.74K | 39.6% | 305.38K | 184.48K |
| Total | −120.90K | -$206.74K | ||||||
Derivative Transactions0
No derivative transactions reported